Endogenous Tim-1 promotes severe systemic autoimmunity and renal disease MRL-Faslpr mice

American Journal of Physiology - Renal Physiology

Volumn 306, Issue 10, 2014, Pages

  Nozaki, Yuji ^a   Richard Kitching, A ^b,c   Akiba, Hisaya ^d   Yagita, Hideo ^d   Kinoshita, Koji ^a   Funauchi, Masanori ^a   Matsumura, Itaru ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MONASH UNIVERSITY   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemokine; Cytokine; Lupus nephritis; Tim 1

Indexed keywords

CCL1 CHEMOKINE; CD19 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; COMPLEMENT COMPONENT C3; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL9 CHEMOKINE; DNA ANTIBODY; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; KIDNEY INJURY MOLECULE 1; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; MONOCLONAL ANTIBODY; RETINOID RELATED ORPHAN RECEPTOR GAMMA; RMT 1 10; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; KIDNEY; KIDNEY DISEASE; KIDNEY FUNCTION; LEUKOCYTE; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHADENOPATHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; REGULATORY T LYMPHOCYTE; SKIN DEFECT; SPLEEN; SURVIVAL; TH1 CELL; TH17 CELL; URINARY EXCRETION;

CHEMOKINE; CYTOKINE; LUPUS NEPHRITIS; TIM-1;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; APOPTOSIS; AUTOIMMUNE DISEASES; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; KIDNEY; KIDNEY DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEMBRANE PROTEINS; MICE; MICE, INBRED MRL LPR; PROTEINURIA; SEVERITY OF ILLNESS INDEX;

EID: 84900802086     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00570.2013     Document Type: Article

References (51)

1. Abe J, Ueha S, Suzuki J, Tokano Y, Matsushima K, Ishikawa S. Increased Foxp3(+) CD4(+) regulatory T cells with intact suppressive activity but altered cellular localization in murine lupus. Am J Pathol 173: 1682-1692, 2008.
2. Albacker LA, Karisola P, Chang YJ, Umetsu SE, Zhou M, Akbari O, Kobayashi N, Baumgarth N, Freeman GJ, Umetsu DT, DeKruyff RH. TIM-4, a receptor for phosphatidylserine, controls adaptive immunity by regulating the removal of antigen-specific T cells. J Immunol 185: 6839-6849, 2010.
3. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy-review of a new approach. Pharmacol Rev 55: 241-269, 2003.
4. Blenman KR, Duan B, Xu Z, Wan S, Atkinson MA, Flotte TR, Croker BP, Morel L. IL-10 regulation of lupus in the NZM2410 murine model. Lab Invest 86: 1136-1148, 2006.
5. Bossie A, Vitetta ES. IFN-gamma enhances secretion of IgG2a from IgG2a-committed LPS-stimulated murine B cells: implications for the role of IFN-gamma in class switching. Cell Immunol 135: 95-104, 1991.
6. Chesnutt MS, Finck BK, Killeen N, Connolly MK, Goodman H, Wofsy D. Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr mice. Clin Immunol Immunopathol 87: 23-32, 1998.
7. Daha NA, Banda NK, Roos A, Beurskens FJ, Bakker JM, Daha MR, Trouw LA. Complement activation by (auto-) antibodies. Mol Immunol 48: 1656-1665, 2011.
8. de Souza AJ, Oriss TB, O'Malley KJ, Ray A, Kane LP. T cell Ig and mucin 1 (TIM-1) is expressed on in vivo-activated T cells and provides a costimulatory signal for T cell activation. Proc Natl Acad Sci USA 102: 17113-17118, 2005.
9. Díaz Gallo C, Jevnikar AM, Brennan DC, Florquin S, Pacheco-Silva A, Kelley VR. Autoreactive kidney-infiltrating T-cell clones in murine lupus nephritis. Kidney Int 42: 851-859, 1992.
10. Ding Q, Yeung M, Camirand G, Zeng Q, Akiba H, Yagita H, Chalasani G, Sayegh MH, Najafian N, Rothstein DM. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest 121: 3645-3656, 2011.
11. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3: 944-950, 2002.
12. Foster MH, Kelley VR. Lupus nephritis: update on pathogenesis and disease mechanisms. Semin Nephrol 19: 173-181, 1999.
13. Huang XR, Kitching AR, Tipping PG, Holdworth SR. Interleukin-10 inhibits macrophage-induced glomerular injury. J Am Soc Nephrol 11: 262-269, 2000.
14. Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 179: 305-310, 1994.
15. Janssen U, Ostendorf T, Gaertner S, Eitner F, Hedrich HJ, Assmann KJ, Floege J. Improved survival and amelioration of nephrotoxic nephritis in intercellular adhesion molecule-1 knockout mice. J Am Soc Nephrol 9: 1805-1814, 1998.
16. Kinoshita K, Tesch G, Schwarting A, Maron R, Sharpe AH, Kelley VR. Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice. J Immunol 164: 6046-6056, 2000.
17. Kinoshita K, Yamagata T, Nozaki Y, Sugiyama M, Ikoma S, Funauchi M, Kanamaru A. Blockade of IL-18 receptor signaling delays the onset of autoimmune disease in MRL-Faslpr mice. J Immunol 173: 5312-5318, 2004.
18. Kitching AR, Tipping PG, Huang XR, Mutch DA, Holdsworth SR. Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice. Kidney Int 52: 52-59, 1997.
19. Kuchroo VK, Umetsu DT, DeKruyff RH, Freeman GJ. The TIM gene family: emerging roles in immunity and disease. Nat Rev Immunol 3: 454-462, 2003.
20. Kulkarni O, Anders HJ. Chemokines in lupus nephritis. Front Biosci 13: 3312-3320, 2008.
21. Kyttaris VC, Zhang Z, Kuchroo VK, Oukka M, Tsokos GC. IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/ 6-lpr/lpr mice. J Immunol 184: 4605-4609, 2010.
22. Lit LC, Wong CK, Li EK, Tam LS, Lam CW, Lo YM. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus. J Rheumatol 34: 89-96, 2007.
23. Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 118: 3420-3430, 2008.
24. Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 197: 489-501, 2003.
25. Meyers JH, Sabatos CA, Chakravarti S, Kuchroo VK. The TIM gene family regulates autoimmune and allergic diseases. Trends Mol Med 11: 362-369, 2005.
26. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16: 219-230, 2007.
27. Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8: 34-47, 2008.
28. Nozaki Y, Nikolic-Paterson DJ, Snelgrove SL, Akiba H, Yagita H, Holdsworth SR, Kitching AR. Endogenous Tim-1 (Kim-1) promotes T-cell responses and cell-mediated injury in experimental crescentic glomerulonephritis. Kidney Int 81: 844-855, 2012.
29. Nozaki Y, Nikolic-Paterson DJ, Yagita H, Akiba H, Holdsworth SR, Kitching AR. Tim-1 promotes cisplatin nephrotoxicity. Am J Physiol Renal Physiol 301: F1098-F1104, 2011.
30. + T-cell clones promote nephritis in lupus-prone mice. Kidney Int 82: 969-979, 2012.
31. + Th1 cells are effectors in lupus nephritis-but what are their targets? Kidney Int 82: 947-949, 2012.
32. Panzer U, Steinmetz OM, Stahl RA, Wolf G. Kidney diseases and chemokines. Curr Drug Targets 7: 65-80, 2006.
33. Peng SL, Madaio MP, Hughes DP, Crispe IN, Owen MJ, Wen L, Hayday AC, Craft J. Murine lupus in the absence of T cells. J Immunol 156: 4041-4049, 1996.
34. Pisetsky DS, McCarty GA, Peters DV. Mechanisms of autoantibody production in autoimmune MRL mice. J Exp Med 152: 1302-1310, 1980.
35. Pisitkun P, Ha HL, Wang H, Claudio E, Tivy CC, Zhou H, Mayadas TN, Illei GG, Siebenlist U. Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity 37: 1104-1115, 2012.
36. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med 358: 929-939, 2008.
37. Rong S, Park JK, Kirsch T, Yagita H, Akiba H, Boenisch O, Haller H, Najafian N, Habicht A. The TIM-1:TIM-4 pathway enhances renal ischemia-reperfusion injury. J Am Soc Nephrol 22: 484-495, 2011.
38. Santoro TJ, Portanova JP, Kotzin BL. The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice. J Exp Med 167: 1713-1718, 1998.
39. Scalapino KJ, Tang Q, Bluestone JA, Bonyhadi ML, Daikh DI. Suppression of disease in New Zealand Black/New Zealand White lupusprone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol 177: 1451-1459, 2006.
40. Schwarting A, Wada T, Kinoshita K, Tesch G, Kelley VR. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. J Immunol 161: 494-503, 1998.
41. Segerer S, Schlondorff D. B cells and tertiary lymphoid organs in renal inflammation. Kidney Int 73: 533-537, 2008.
42. Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, Izui S. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest 97: 1597-1604, 1996.
43. Bossie A, Vitetta ES. IFN-gamma enhances secretion of IgG2a from IgG2a-committed LPS-stimulated murine B cells: implications for the role of IFN-gamma in class switching. Cell Immunol 135: 95-104, 1991.
44. Teichmann LL, Kashgarian M, Weaver CT, Roers A, Müller W, Shlomchik MJ. B cell-derived IL-10 does not regulate spontaneous systemic autoimmunity in MRL. Fas(lpr) mice. J Immunol 188: 678-685, 2012.
45. Turner JE, Paust HJ, Steinmetz OM, Peters A, Riedel JH, Erhardt A, Wegscheid C, Velden J, Fehr S, Mittrücker HW, Tiegs G, Stahl RA, Panzer U. CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis. J Am Soc Nephrol 21: 974-985, 2010.
46. Uchida Y, Ke B, Freitas MC, Ji H, Zhao D, Benjamin ER, Najafian N, Yagita H, Akiba H, Busuttil RW, Kupiec-Weglinski JW. The emerging role of T cell immunoglobulin mucin-1 in the mechanism of liver ischemia and reperfusion injury in the mouse. Hepatology 51: 1363-1372, 2010.
47. Umetsu SE, Lee WL, McIntire JJ, Downey L, Sanjanwala B, Akbari O, Berry GJ, Nagumo H, Freeman GJ, Umetsu DT, DeKruyff RH. TIM-1 induces T cell activation and inhibits the development of peripheral tolerance. Nat Immunol 6: 447-454, 2005.
48. +CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 178: 2579-2588, 2007.
49. Xiao S, Brooks CR, Zhu C, Wu C, Sweere JM, Petecka S, Yeste A, Quintana FJ, Ichimura T, Sobel RA, Bonventre JV, Kuchroo VK. Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice. Proc Natl Acad Sci USA 109: 12105-12110, 2012.
50. Xiao S, Najafian N, Reddy J, Albin M, Zhu C, Jensen E, Imitola J, Korn T, Anderson AC, Zhang Z, Gutierrez C, Moll T, Sobel RA, Umetsu DT, Yagita H, Akiba H, Strom T, Sayegh MH, DeKruyff RH, Khoury SJ, Kuchroo VK. Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function. J Exp Med 204: 1691-1702, 2007.
51. Yin Z, Bahtiyar G, Zhang N, Liu L, Zhu P, Robert ME, McNiff J, Madaio MP, Craft 2002 J. IL-10 regulates murine lupus. J Immunol 169: 2148-2155, 2002.